Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

471 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Circulating cardiovascular biomarkers in recurrent atrial fibrillation: data from the GISSI-atrial fibrillation trial.
Latini R, Masson S, Pirelli S, Barlera S, Pulitano G, Carbonieri E, Gulizia M, Vago T, Favero C, Zdunek D, Struck J, Staszewsky L, Maggioni AP, Franzosi MG, Disertori M; GISSI-AF Investigators. Latini R, et al. Among authors: masson s. J Intern Med. 2011 Feb;269(2):160-71. doi: 10.1111/j.1365-2796.2010.02287.x. Epub 2010 Oct 22. J Intern Med. 2011. PMID: 20964739 Free article. Clinical Trial.
Sex differences in factors associated with heart failure and diastolic left ventricular dysfunction: a cross-sectional population-based study.
Cesaroni G, Mureddu GF, Agabiti N, Mayer F, Stafoggia M, Forastiere F, Latini R, Masson S, Davoli M, Boccanelli A; PREDICTOR Study Group. Cesaroni G, et al. Among authors: masson s. BMC Public Health. 2021 Feb 27;21(1):415. doi: 10.1186/s12889-021-10442-3. BMC Public Health. 2021. PMID: 33639910 Free PMC article.
Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: the AREA-in-CHF study.
de Simone G, Chinali M, Mureddu GF, Cacciatore G, Lucci D, Latini R, Masson S, Vanasia M, Maggioni AP, Boccanelli A; AREA-in-CHF Investigators. de Simone G, et al. Among authors: masson s. Nutr Metab Cardiovasc Dis. 2011 Oct;21(10):783-91. doi: 10.1016/j.numecd.2010.02.012. Epub 2010 Jun 17. Nutr Metab Cardiovasc Dis. 2011. PMID: 21939839 Clinical Trial.
Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion.
Latini R, Masson S, Jeremic G, Luvarà G, Fiordaliso F, Calvillo L, Bernasconi R, Torri M, Rondelli I, Razzetti R, Bongrani S. Latini R, et al. Among authors: masson s. J Cardiovasc Pharmacol. 1998 Apr;31(4):601-8. doi: 10.1097/00005344-199804000-00020. J Cardiovasc Pharmacol. 1998. PMID: 9554811
Association of high-risk coronary atherosclerosis at CCTA with clinical and circulating biomarkers: Insight from CAPIRE study.
Conte E, Andreini D, Magnoni M, Masson S, Mushtaq S, Berti S, Canestrari M, Casolo G, Gabrielli D, Latini R, Marraccini P, Moccetti T, Modena MG, Pontone G, Gorini M, Maggioni AP, Maseri A; CAPIRE Investigators, Steering Committee; Imaging Core Laboratory; Centralized biobank and biomarker core laboratory; Central ECG Reading; Psychologists CRF Group; Participating Centers and Investigators. Conte E, et al. Among authors: masson s. J Cardiovasc Comput Tomogr. 2021 Jan-Feb;15(1):73-80. doi: 10.1016/j.jcct.2020.03.005. Epub 2020 Jun 11. J Cardiovasc Comput Tomogr. 2021. PMID: 32563713
471 results